RecruitingNot ApplicableNCT07317232
Ayahuasca, Esketamine and Premenstrual Symptoms
Effects of a Single Dose of Ayahuasca or Esketamine on the Menstrual Cycle and Premenstrual Symptoms: a Randomized, Double-Blind Study
Sponsor
University of Sao Paulo
Enrollment
20 participants
Start Date
Dec 20, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine on premenstrual symptoms.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years
Inclusion Criteria1
- healthy volunteers
Exclusion Criteria1
- psychiatric and other medical comorbidities
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAyahuasca
oral ayahuasca
DRUGEsketamine
oral esketamine
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07317232